Ascentage Pharma Group International
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AAPGV research report →
Price Chart
About the company
Ascentage Pharma Group International is a clinical-stage biotechnology company focused on developing therapeutic solutions for various cancers, chronic hepatitis B virus (HBV) infection, and age-related conditions, primarily within Mainland China. Its flagship product candidate, HQP1351, is a BCR-ABL inhibitor specifically designed to target BCR-ABL1 mutants, notably those harboring the T315I mutation. The company's extensive pipeline further comprises: APG-2575, an orally administered, selective Bcl-2 inhibitor for hematologic malignancies and solid tumors.
- CEO
- Dajun Yang
- IPO
- 2025
- Employees
- 574
- HQ
- Suzhou, CN
Get TickerSpark's AI analysis on AAPGV
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $127.31M
- P/E
- -8.41
- PEG
- 0.05
- P/S
- 19.06
- P/B
- 8.13
- EV/EBITDA
- -9.28
- Div Yield
- 0.00%
- Gross Margin
- 84.09%
- Op Margin
- -210.42%
- Net Margin
- -216.74%
- ROE
- -123.61%
- ROIC
- -33.71%
Latest fiscal year · YoY change
- Revenue
- $980.65M+341.8%
- Gross Profit
- $951.57M+397.1%
- Op Income
- $-369,730,000
- Net Income
- $-405,433,000+56.2%
- EPS
- $-1.34+89.8%
- OCF Growth
- +84.7%
- FCF Growth
- +82.7%
- 52W High
- $18.00
- 52W Low
- $16.50
- 50D MA
- $17.41
- 200D MA
- $17.41
- Beta
- 1.10
- RSI (14)
- 59
- Avg Volume
- 497.68K
No earnings-call transcripts are available for AAPGV yet.
- Free Float
- 2799.5%
- Shares Outstanding
- 7.33M
- Float Shares
- 205.06M
Our AAPGV coverage
Recent articles, reports, and earnings notes.
No research on AAPGV yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate AAPGV report →